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Cysteine-Rich LIM-Only Proteins CRP1
and CRP2 Are Potent Smooth Muscle
Differentiation Cofactors
dimerization domain, termed the MADS box, which inte-
grates intracellular signals and assists as a docking sur-
face for the binding of cofactors that may confer the
regulation of specific gene programs (reviewed in Reecy
et al., 1999; Gineitis and Treisman, 2001). The knockout
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muscle mesoderm during mouse embryogenesis (Ar-3 Department of Surgery
senian et al., 1998). While numerous studies have estab-4 Department of Medicine
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sufficient to direct SMC differentiation from committed
progenitor cells.
We sought to identify proteins that might act to orga-
Summary nize higher-order multiprotein complexes that contain
SRF and stimulate SMC-restricted gene transcription in
Cysteine-rich LIM-only proteins, CRP1 and CRP2, ex- an SRE-dependent and developmental signal-respon-
pressed during cardiovascular development act as sive manner. Recently, Sepulveda et al. (2002) demon-
bridging molecules that associate with serum re- strated that the expression of SRF, Nkx2-5, and GATA4
sponse factor and GATA proteins. SRF-CRP-GATA was central for activation of embryonic cardiac -actin
complexes strongly activated smooth muscle gene gene activity. Nishida et al. (2002) showed the combina-
targets. CRP2 was found in the nucleus during early torial interaction of SRF-, Nkx-3.2-, and GATA-6-acti-
stages of coronary smooth muscle differentiation from vated promoters of smooth muscle genes. Wang et al.
proepicardial cells. A dominant-negative CRP2 mutant (2001) showed that myocardin, a SAP factor enriched
blocked proepicardial cells from differentiating into during cardiogenesis, also served as a powerful SRF
smooth muscle cells. Together with SRF and GATA coaccessory factor. However, the precise combination
proteins, CRP1 and CRP2 converted pluripotent 10T1/2 of regulatory factors that fosters distinct cardiac and
fibroblasts into smooth muscle cells, while muscle LIM smooth muscle cell lineages has not been previously
protein CRP3 inhibited the conversion. Thus, LIM-only elucidated. Of interest in this regard are the LIM domain-
proteins of the CRP family play important roles in or- containing members of the cysteine-rich protein (CRP)
ganizing multiprotein complexes, both in the cyto- family.
plasm, where they participate in cytoskeletal remodel- LIM domains are double-zinc finger-like structures
ing, and in the nucleus, where they strongly facilitate that mediate protein-protein interactions and may target
proteins to distinct subcellular locations and mediatesmooth muscle differentiation.
assembly of multimeric protein complexes (Dawid et al.,
1995; Louis et al., 1997). Each member of the CRP family
Introduction contains two LIM domains with associated glycine-rich
repeats. Three members of the CRP family (CRP1,
The cardiovascular system is among the earliest organs CRP2/SmLIM, and CRP3/MLP) have been characterized
to form in mammals. De novo gene expression of smooth in vertebrates (Liebhaber et al., 1990; Weiskirchen et al.,
muscle contractile protein genes appears in the heart- 1995; Arber et al., 1994), and all three appear to have
forming regions, providing molecular markers for pro- comparable functions in different cell types. CRP1 is
myocardial cells well before overt cardiac morphogene- expressed in multiple adult organs, including those en-
sis (Colas et al., 2000). Robust expression of the smooth riched in smooth muscle, such as arteries, stomach,
muscle -actin (SMA) gene marked the onset of differen- gizzard, and intestine (Henderson, et al., 1999). CRP2 is
tiation of cardiac cells and demonstrated coexpression expressed mainly in vascular SMCs and is downregu-
of both smooth muscle and striated -actin genes within lated upon their dedifferentiation and proliferation in
myogenic cells (Ruzicka and Schwartz, 1988). Cardio- response to stress or injury, as occurs in arteriosclerosis
vascular smooth muscle differentiation depends upon (Jain et al., 1996). Expression of CRP3 is limited to stri-
the integration of complex signaling inputs with activa- ated muscle cells of heart and skeletal muscle, and
tion of serum response factor (SRF)-dependent tran- CRP3-deficient mice develop heart failure soon after
scription. SRF contains a highly conserved DNA binding/ birth (Arber et al., 1997).
One distinguishing feature of the three CRPs is their
association with adhesion plaques and with filamentous*Correspondence: schwartz@bcm.tmc.edu
actin. These proteins do not bind actin directly, but all8 These authors contributed equally to this work.
9 These labs contributed equally to this work. three interact with both the actin crosslinking protein
Developmental Cell
108
-actinin and the adhesion plaque protein zyxin and Synergistic Interactions of CRPs with SRF
and GATA Factors Transactivated SMCmay regulate the stability and structure of adhesion
complexes. (Schmeichel and Beckerle, 1994; Arber and Target Gene Promoters
Both LIM-only proteins (including the CRPs) and GATACaroni, 1996; Pomies et al., 1997) However, it is our
hypothesis that this cytoplasmic role for the CRP pro- transcription factors contain similar zinc finger motifs
that could potentially heterodimerize. For example,teins is not their only, or, possibly, even their most criti-
cal, function during cell differentiation. Here we report Lmo2, a LIM-only protein, was demonstrated as an as-
sociating molecule with GATA1 in transcriptional com-that the restricted expression of CRP1 and CRP2 in early
vertebrate embryos was coincident with the earliest ap- plex assembly important for erythropeoisis (Wadman et
al., 1997; Mead et al., 2001). This suggested the possibil-pearance of smooth muscle gene targets and nascent
myocardial cells. CRP2 was found in the nucleus during ity that LIM-only CRP1 or CRP2 may interact with GATA
family members enriched in the cardiovascular system,the early differentiation of smooth muscle cells. Further-
more, we provide evidence to suggest that CRP1 and such as GATA4 and GATA6. Previously, synergism was
shown between SRF and GATA4, GATA5, and GATA6CRP2 function as transcription cofactors that form com-
plexes with SRF and GATA6 to promote de novo upregu- in mediating the activation of SRF-dependent gene pro-
moters, including the SMC marker genes SMA, SM22,lation of smooth muscle-specified genes, central for car-
diovascular SMC differentiation. and SM -actin (Belaguli et al., 2000).
We next asked whether CRPs could facilitate tran-
scriptional activity of the SRF-GATA-complex, espe-Results
cially of promoters encoding the SMC target genes. Ex-
pression of CRP1, CRP2, and/or CRP3 alone hadAvian CRP1 and CRP2 Genes Are Coexpressed
minimal effects on SMA reporter activity in a heterolo-during Early Cardiovascular Development
gous system with monkey CV1 fibroblasts (Figure 2A,In situ hybridization analysis revealed CRP1 expression
lanes 6–8). Pairings with SRF and/or with GATA2,in the lateral plate precardiac mesoderm at HH7 (Figure
GATA4, or GATA6, however, resulted in coactivation of1A) prior to the migration and fusion of the bilateral
about 10- to 30-fold above basal levels (Figure 2A, lanescardiac precursors. Previously, we observed that SRF
9–23). In the presence of SRF and GATA factors, additiontranscripts overlapped with GATA4 and Nkx2-5 mRNA
of CRP1 or CRP2 coactivated the SMA promoter by(Wei et al., 2001; Sepulveda et al., 2002) in regions where
several orders of magnitude (Figure 2A, lanes 24, 25,SMA and cardiac -actin gene activity were superim-
27, 28, 30, and 31). Weaker activation was found withposed in early committed myocardial cells of the heart
CRP3 (Figure 2A, lanes 26, 29, and 32). Previously, we(Ruzicka and Schwartz, 1988). Thus, CRP1 appears co-
have shown that GATA4 and GATA6 are equivalent inincident with cardiac-restricted transcription factors
cotransfection assays with SRF (Belaguli et al., 2000).during the onset of cardiac differentiation. At HH10,
Again, the two GATA factors can substitute for eachCRP1 expression was also evident in the underlying
other in combinatorial interactions with CRP2 and SRFforegut endoderm and the myocardium, but absent in
to drive SMA promoter (Figure 3A, lanes 28 and 31).the endocardium and the overlying pharynx (Figure 1A,
Even GATA2, an important transcription factor in eryth-lower panel). Cardiac-specific expression of CRP1 is
rogenesis and myogenesis, was able to augment SRF-maintained as the heart takes on the familiar looped
CRP-induced transactivation of SMA promoter (Figuretube appearance by stage HH12. Figure 1B revealed
3A, lanes 24–26). Thus, CRP1, CRP2, and the GATACRP2 expression beginning at HH7 in the anterior por-
factors appeared to be interchangeable, while CRP3tion of the crescent and the region of the developing
was nonequivalent.head fold and anterior intestinal portal. By HH12, CRP2
Other smooth muscle gene promoters were also re-appears in the left and right dorsal aortae, in the truncus
sponsive to this triple-factor combination in fibroblastsand bulbus arteriosus, with some degree of ventricular
(Figure 2B). The SM22 promoter, which contains twooverlap (the bulboventricular region), and in a discrete
SREs, was activated about 600-fold by the combinationarea of expression at the junction of the vitelline veins
of these three factors, while the549Calponin-I reporterin the sinus venosus (Figure 1B, lower panel), consistent
(Miano et al., 2000), with three intronic SREs, and thewith the upregulation of SMA expression and VSMC
smooth muscle -actin SMGA5 promoter, with fourdifferentiation (Ruzicka and Schwartz, 1988).
SREs, were activated about 250- and 300-fold, respec-We previously reported that CRP2 expression was
tively (Figure 2B). In contrast, weak coactivation wasincreased in proepicardial cells during differentiation to
seen with the single-SRE-containing c-fos promotercoronary SMCs in vitro (Landerholm et al., 1999). Using
(Figure 2C). Furthermore, mutation in either SRE on therabbit anti-chicken CRP2 (Louis et al., 1997), we found
SMA promoter reduced the synergistic transactivationendogenous CRP2 to be localized to the nucleus during
by these transcription factors (Figure 3D). In the double-initial activation of SMC-specific transcription in proepi-
SRE mutant reporter, the responsiveness to CRP2 iscardial cells (Figure 1C, i). Later, as these nascent SMCs
completely abolished (Figure 3D). These results suggestmatured to a more fully differentiated phenotype, CRP2
that most of the synergistic coactivation by CRP2 requireswas upregulated and became localized to the cytoskele-
efficient binding of SRF to multiple SREs. Consistentton (Figure 1C, ii and iii) This cellular distribution in ma-
with this idea, substitution of the transactivation-defec-ture coronary SMCs is consistent with the existing ex-
tive SRFC mutant (Belaguli et al., 2000) for wild-typepression and functional data for CRP2 in developing
SRF in combination with GATA6 and CRP2 resulted inand mature vascular smooth muscle (Jain et al., 1996;
Louis et al., 1997). a greater than 95% reduction in coactivation of these
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Figure 1. LIM-Only CRP1 and CRP2 Genes Expressed during Early Chick Embryonic Cardiovascular Development
(A) Whole-mount in situ hybridization showed CRP1 transcription in the lateral plate precardiac mesoderm as early as HH7, prior to the
migration and fusion of the bilateral cardiac precursors. CRP1 is cardiac restricted at HH10 and as the heart becomes looped tube appearance
by stage HH12. Cross-section of the cardiogenic region at HH10 showed CRP1 expression in the foregut endoderm and the epimyocardium
(lower panel).
(B) CRP2 is expressed in the region of the developing head fold and outflow tract at early stages (HH7 and HH8). CRP2 expressed in the left
and right dorsal aorta and the truncus and bulbus arteriosus (HH12). The cross-section of HH12 embryo (lower panel) showed CRP2 expression
to some degree of ventricular overlap (the bulboventricular region) and in a discrete area of expression at the junction of the vitelline veins
and in the sinus venosus.
(C) Endogenous CRP2 expression in proepicardial cells during differentiation to CoSMCs. Endogenous CRP2 is localized to the nucleus in
epicardial cells during the period of initial activation of SMC-specific gene transcription (i) and upon epithelial to mesenchymal transformation
(ii) and progression to mature SMCs (iii).
multi-SRE-containing smooth muscle gene promoters 5, and 6). Cotransfection of wild-type CRP2 expression
(Figure 2B and 2C). vector stimulated the reporter activity 5-fold (Figure 3A,
lane 5), whereas addition of a fusion CRP2 protein con-
taining a viral transactivation domain, VP16, greatly aug-CRP2 Coassociated with Nuclear
mented Gal4 reporter activity, 30-fold (Figure 3A, laneTranscription Factors
6). These results suggest that the minimal DNA bindingTo test whether the synergistic activation displayed by
domain of SRF, the MADS box, facilitated recruitmentCRP2, SRF, and GATA factors on SMC target genes
of CRP2 to the Gal4 minimal promoter.requires their physical interaction, we performed a mam-
To further determine whether CRP2, SRF, and GATA6malian two-hybrid study to determine whether CRP2
can physically associate in cells, we performed coimmu-was recruited by SRF to target DNA (Figure 3A). CV1
noprecipitation assays of epitope-tagged proteins. CV1cells were transfected with Gal4 UAS-luciferase reporter
fibroblasts were cotransfected with constructs overex-and expression plasmids encoding SRF MADS box-Gal4
DNA binding domain fusion protein (Figure 3A, lanes 4, pressing V5-tagged CRP2, HA-tagged SRF, Myc-tagged
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Figure 2. Combinatorial Interactions among CRPs, SRF, and GATA Factors Facilitated Robust Activation of SMC Target Gene Promoters
(A) Transcriptional activity of SMA was measured in CV1 cells with a luciferase reporter assay, with the indicated combination of expression
plasmids. The results of three repeated transient cotransfection experiments performed in duplicate are presented in Figures 2A–2D. Values
are expressed as fold activation increases in luciferase activity SEM compared with the level of activity with empty expression vector alone.
(B) Transactivation assay of CArG box-containing SMC-restricted genes in CV1 cells. The promoter-reporter constructs used are shown
schematically.
(C) Minimal SRE reporter, c-fos SRE1-Luc, results in weak coactivation in CV1 cells.
(D) Mutation in either SRE on the SMA promoter reduces the synergistic transactivation in CV1 cells, while double-SRE mutation results in
null activity. Relative transactivation was determined by comparison to the wild-type promoter-reporter.
GATA6, and FLAG-tagged E12. The non-tissue-specific into equal aliquots and immunoprecipitated with anti-
bodies directed against each epitope-tagged protein.basic helix-loop-helix (bHLH) transcription factor E12
served as a negative control. Cell lysates were divided As seen in the immunoblot analysis, CRP2, SRF, and
SMC CRPs Are Transcription Cofactors
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Figure 3. CRP2 Coassociated with SRF and GATA Factors and Formed In Vivo Protein Complexes
(A) Mammalian two-hybrid assays determined that the minimal DNA binding domain of SRF (MADS box) facilitated the recruitment of CRP2
to the Gal4 minimal promoter. A schematic model of assayed interactions is shown in this panel.
(B) Coimmunoprecipitation (co-IP) experiments demonstrate that CRP2, SRF, and GATA6 proteins coassociate. Whole-cell lysates (WCL) of
CV1 cells cotransfected with pcDNA3.1-V5-CRP2, pCGN-SRF (HA-tagged), pcDNA3.1-myc-GATA6, and pcDNA3.1-FLAG-E12 were subjected
to IP with anti-V5 (lane 1), anti-HA (lane 2), anti-Myc (lane 3), or anti-FLAG (lane 4). IP products were analyzed by Western immunoblot (WB)
with anti-V5 for CRP2 (top panel), anti-HA for SRF (second panel), anti-Myc for GATA6 (third panel), and anti-FLAG for E12 (bottom panel).
Ten percent of whole-cell lysate (WCL) was loaded in lane 5.
(C) EMSAs of the SMA promoter show that CRP2 and GATA4 recruited by SRF vastly increased cooperative SRF DNA binding affinity. The
faster complex represents the occupation of either SRE1 and/or SRE2 (C1). The second, slower complex represents occupation of both SRE1
and SRE2 (C2). Ternary complexes were also resolved above C1 and C2. The addition of SRF antibody resulted in two super-shifted complexes
with reduced levels of C1 and C2 complexes, while the addition of anti-GST-CRP2 antibody only reduced the level of C1 complex. Anti-GATA4
antibody did not produce a super shift, indicating possible interference of the protein-protein bind site with the epitope.
GATA6 coimmunoprecipitated with each other (Figure In Figure 3C, EMSAs were performed with a subopti-
mal amount of SRF, resulting in a barely detected com-3B, lanes 1, 2, and 3), while none of the transfactors
interacted with E12 (Figure 3B, lane 4). plex (C1) on the SMA promoter (Figure 3C, lanes 1 and
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Figure 4. CRP2 Is a Bridging Molecule
Fine mapping revealed obligatory roles for intact LIM domains of CRP2 and the C-terminal zinc finger of GATA protein for coassociation and
transactivation.
(A) The N-terminal LIM domain mediates SRF-CRP2 binding, while the C-terminal LIM is required for CRP2-GATA4 coassociation. Pull-down
analyses were performed on [35S]methionine-labeled, in vitro-translated proteins with GST-SRF (lane 3) or MBP-GATA4 fusion protein (lane
6). GST (lane 2) or MBP (lane 5) protein was used as negative control. The associated proteins were visualized by autoradiography. One-fifth
of the amount of labeled translated proteins was loaded as positive control (lanes 1 and 4).
(B) Luciferase assay in CV1 cells correlates with the binding specificity of CRP2 mutants and the synergistic transactivation on SMA reporter.
(C) GST pull-down analysis was performed on [35S]methionine-labeled, in vitro-translated proteins with GST control (lane 2) or GST-CRP (lane
3) fusion protein. The associated proteins were visualized by autoradiography. One-fifth of the amount of labeled translated proteins was
loaded as positive control (lane 1).
(D) Luciferase assay in CV1 cells correlates the binding specificity of GATA4 mutants and the synergistic transactivation on SMA reporter.
15). Increasing amounts of CRP2 added to a constant SRF binding as a major complex, demonstrating occu-
pation of either the first and/or the second SRE. How-suboptimal amount of SRF caused increased SRF bind-
ing (Figure 3C, lanes 5–8), while GATA4 also stimulated ever, CRP2 and GATA4 together strongly increased SRF
binding, resulting in two well-resolved complexes (C1SRF binding (Figure 3C, lane 4). Even though CRP2 and
GATA4 were unable to bind to the SMA promoter by and C2; Figure 3C, lanes 11–13 and 16), indicating pro-
gressive occupancy of two SREs in the SMA promoter.themselves (Figure 3C, lanes 9 and 10), they facilitated
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These two complexes were super shifted by an antibody with GST-CRP2 (Figure 4C). Deletion of the N-terminal
region proximal to the zinc finger revealed an N-terminalagainst SRF (Figure 3C, lanes 14 and 17). An antibody
against the recombinant GST-CRP2 resulted in dimin- activation domain (Figure 4D, lane 14), while deletion of
the N-terminal zinc finger resulted in a strong activationished C1 band (Figure 3C, lane 19), while anti-GATA4
did not super shift the complexes (Figure 3C, lane 18), (Figure 4D, lane 15), consistent with loss of inhibitory
activity. We also confirmed that GATA4 and GATA6 arepossibly because of interference of the protein-protein
binding domain with the epitope. Thus, CRP2 and equivalent in these physical binding experiments (Fig-
ures 4A and 4C). Together, these physical associationGATA4 recruited by SRF significantly increased cooper-
ative SRF DNA binding affinity. and complementary cotransfection analyses identified
specific protein-protein interaction domains that are re-
sponsible for CRP2-SRF and CRP2-GATA binding.CRP2 Functioned as a Bridging Molecule for
Association with SRF and GATA Factors
We mapped the domains that are required for physical CRP2-Dependent Expression of Endogenous
association of CRP2, SRF, and GATA factor. Previously, SMC Genes
LIM-only protein Lmo2 served as a bridging molecule, On the basis of the observation that synergistic interac-
assembling a transcription complex important in hema- tion among CRP2, SRF, and GATA factors produced
topoiesis (Wadman et al., 1997). As shown in Figure 4A, robust promoter activity, we tested the effects of these
the two LIM domains of CRP2 independently coassoci- transcription factors in combination in murine pluripo-
ated with SRF (N-terminal LIM) and with GATA protein tent 10T1/2 mesenchymal cells. Within two days of co-
(C-terminal LIM), respectively. Deletion of the first zinc transfection with CMV-driven expression plasmids en-
finger (in CRP2ZF1 and C2ZF2ZF3 mutants) or com- coding SRF, GATA6 in combination with CRP1 or CRP2,
plete removal of both zinc fingers (in CRP2N mutant) but not CRP3, transcripts encoding SMA, SM22, SM-
of the N-terminal LIM domain of CRP2 disrupts its bind- calponin, SM-MHC, and SMA was detected by RT-
ing to GST-SRF (Figure 4A, lanes 1–3) and reduced co- PCR assays (Figure 5A, lanes 3–5). Transfection with
activation of SMA promoter activity (Figure 4B, lanes SRF alone or with an empty control vector did not result
8–10 and 14–16). On the other hand, intact C-terminal in gene upregulation (Figure 5A, lanes 1 and 2). Also,
LIM motif is necessary for CRP2’s interaction with transfection efficiency (50%) of individual plasmid ex-
GATA4. As shown, removal of the second zinc finger pression vectors was not altered greatly in cotransfec-
(in CRP2ZF4 and C2ZF2ZF3 mutants) or complete tion experiments and was reduced to only 20% for three
removal of both zinc fingers (in CRP2C mutant) of the plasmid vector cotransfections. Furthermore, in this
C-terminal LIM domain of CRP2 abolished its binding transdifferentiation assay, both immunofluorescence
to MBP-GATA4 (Figure 4A, lanes 4–6). Retention of the (Figure 5B) and Western blot (Figure 5C) analyses have
N-terminal LIM domain, even in the presence of partial confirmed the expression of each of these SMC-specific
or complete deletion of the C-terminal LIM domain of proteins, including SM-calponin and SM-MHC. Striated
CRP2 (in CRP24 and CRP2C mutants, respectively), muscle-specific sarcomeric -actin and cardiac -actin
was sufficient for robust coactivation of SMA promoter were not induced (Figures 5A and 5C), indicating that
activity (Figure 4B, lanes 11, 12, 17, and 18). These re- the differentiation pattern is uniquely SMC specific. To-
sults revealed three important observations. First, intact gether, expression of CRP2 with SRF and GATA factors
LIM motif is obligatory for its function as a protein- activated an SMC lineage-specific gene program in
protein interface: “half-LIM” is not equivalent to a func- 10T1/2 cells.
tional zinc-finger motif, which was known for mediating
protein-protein and protein-DNA interaction. Second,
the ability of each LIM domain of CRP2 to function inde- Dominant-Negative CRP2 Blocked Vascular
Smooth Muscle Differentiationpendently, with the N-terminal and C-terminal LIM coas-
sociated with SRF and GATA protein, respectively, af- of Proepicardial Cells
From the physical mapping of CRP2, we observed thatfirms its adaptor role, as previously studies have
suggested (Konrat et al., 1998). Lastly, the N-terminal the CRP2N mutant (aa 112–193) binds strongly with
GATA4 but was null for both coassociation and coactiva-LIM domain of CRP2 has an important functional role,
required for the synergistic transactivation. tion with SRF. To check whether CRP2N could act as
a dominant-negative mutant, we performed cotransfec-CRP2 also coassociated with GATA factors GATA4
and GATA6 in solution. This interaction is mediated tion assays with SRF, GATA6, and wild-type CRP2 (Fig-
ure 6A). In a dose-dependent manner, CRP2N effec-through the C-terminal zinc finger of GATA4 (amino
acids [aa] 250–304), deduced from the evidence that tively shut down co activation of SMA-Luc reporter
(Figure 6A, lanes 5–7). The other C-terminal LIM deletionG4C mutant (lacking aa 336–440) coassociated with
GST-CRP2 while G4CZF2 mutant (without aa 250– mutant, CRP2C (aa 1–112), had no effect in this co-
transfection assay (Figure 6A, lanes 8–10).440) did not bind to GST-CRP2 (Figure 4C). Analysis of
the GATA4 mutants in coactivation assays with the SMA Next, we went back to the PEO system to determine
whether CRP2 was functionally important for SMC dif-promoter also indicated that the C-terminal zinc finger
of GATA4 is required for transcriptional activity (Figure ferentiation. Freshly isolated proepicardial cells were
transfected with dominant-negative CRP2N and exam-4D, lane 17). The basic region (aa 305–335) of GATA4
was ruled out as a contributor to CRP2-GATA4 associa- ined 2–3 days later for effects on SMC marker protein
expression. In each of three independent experiments,tion because G4ZF1ZF2 (aa 188–304) coassociated
Developmental Cell
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Figure 5. Coexpression of CRP2, SRF, and GATA Factors Induced Endogenous SMC Contractile Genes
(A) RT-PCR analysis indicated activation of endogenous SMC genes in 10T1/2 cells cotransfected with the indicated expression plasmids.
CRP1 and CRP2, but not CRP3, in combination with SRF and GATA4 have a similar effect in SMC transdifferentiation.
(B) Immunofluorescent staining showed expression of the full complement of SMC markers in 10T1/2 cells receiving the triple combination
of factors, compared with the control group.
(C) Western blot analysis confirmed that the induction of SMC target genes in 10T1/2 cells is SMC specific. Cardiac -actin (A) and striated
muscle-specific sarcomeric -actin (C) were not detected in this transdifferentiation study, indicating that the differentiation pattern was SMC
specific. Mouse uterus, heart, and soleus muscle tissues were extracted and used as control for smooth, cardiac, and skeletal muscle,
respectively.
transfection of proepicardial cells with CRP2N inhib- wall, CRP2 may play a scaffold role for assembly and
ited vascular smooth muscle differentiation, as deter- maintenance of a SMC cytoskeleton involved in cell-
mined by expression of the smooth muscle marker substrate adhesion and contractile responses to vaso-
genes SMA, calponin, and SMA (Figure 6B). Expres- active stimuli. A cytoarchitectural role of CRP2 may be
sion of CRP2N inhibited the appearance of calponin- related to the strong binding of the N-terminal LIM do-
positive cells by 50%–70% when compared with un- main to cytoskeleton-associated proteins, such as
treated or empty vector-treated cells. CRP2N inhibited -actinin and zyxin (Louis et al., 1997; Pomies et al.,
the appearance of SMA-positive cells by a similar ex- 1997). How CRP1 and CRP2 move in and out of the
tent. By comparison, we previously found that a domi- nucleus and what signaling pathways control nuclear
nant-negative form of SRF inhibited vascular SMC differ- localization remain to be elucidated.
entiation in this system by about 80% (Landerholm et CRP1 and CRP2 may act as coadaptor molecules that
al., 1999). bridge together two cardiovascular enriched nuclear
factors, SRF and GATA6, into a transcriptosome that
confers strong activation of SMC-specific promoters.Discussion
This strong activation may partly be due to the effect of
CRP2 on the DNA binding activities of SRF and GATA6.We propose a model suggesting that CRP1 and CRP2
Highly related striated muscle-restricted protein CRP3/are multifunctional proteins in the specification of car-
MLP has been shown earlier to potentiate the DNA bind-diovascular lineages (Figure 7). Like CRP2, shown here
ing activity of MyoD (Kong et al., 1997). The recruitment(Figure 1C), CRP1 and CRP3 are also present in the
of NKx2-5 and GATA4 by SRF strongly enhanced SRFnucleus, in addition to the cytoplasm (Arber and Caroni,
DNA binding affinity, a mechanism that allowed for the1996; Jain et al., 1996). In progenitor cells undergoing
formation of higher-ordered cardiac -actin promoterdifferentiation to promyocardial or prevascular SMCs,
DNA binding complexes (Sepulveda et al., 2002). Simi-CRP1 and CRP2 may function as transcriptional coacti-
larly, the combination of GATA4 and CRP2 greatly in-vators involved in the assembly of multiprotein DNA
creased SRF DNA binding affinity and thereby increasedbinding complexes that contain SRF, GATA factors, and
the apparent concentration, or mass, of SRF (Figure 3C).chromatin remodeling enzymes, which collectively me-
Further support for the coadaptor model comes fromdiate SMC-specific gene transcription. In more-fully dif-
ferentiated SMCs, including SMCs in the mature artery related LIM-only proteins, CRP3/MLP, Lmo2, and Lmo3,
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a flexible glycine-rich linker domain that imposes mini-
mal constraint on freedom of movement of the LIM do-
mains (Konrat et al., 1998). Thus, the ability of nuclear
LIM domain proteins and their binding partners to medi-
ate long-range interactions among chromosomal regu-
latory elements (Morcillo et al., 1997; Milan et al., 1998)
may enable CRPs to integrate the activities of several
factors involved in coordinated regulation of gene ex-
pression characteristic of a specific cell type.
Despite extensive similarities in the structure of the
N-terminal LIM domains of CRP1/2/3, sufficient diver-
gence in the structure of the C-terminal LIM domains
and conformational plasticity of these factors may allow
selective recruitment of factors, which, in turn, may de-
termine muscle subtype specificity (Konrat et al., 1998).
In support of this notion, all three CRPs bind with similar
affinities to -actinin and zyxin through their N-terminal
LIM domains, while both the N- and C-terminal LIM
domains of CRP2 and CRP3 specifically interact with
additional unrelated factors (Louis et al., 1997). The N-
and C-terminal LIM domains of CRP3, but not CRP1
and CRP2, bind MyoD (Kong et al., 1997) andI-spectrin,
respectively (Flick and Konieczny, 2000). Similarly, the
N- and C-terminal domains of CRP2 specifically interact
with CRP2BP and PIAS1, respectively (Weiskirchen and
Gressner, 2000; Weiskirchen et al., 2001). Such subtle
differences in the ability of CRPs to recruit distinct regu-
latory factors may be the basis by which CRPs discrimi-
nate among muscle lineages and confer muscle subtype
specificity. CRP3/MLP, by being a poor coactivator of
smooth muscle gene promoters (Figure 2A), may also
act as a de facto competitive inhibitor of CRP2-depen-
dent gene activity (Figure 5A).
Recently, Rando et al. (2000) proposed that actin lo-
calizes to the nuclear matrix. Actin and actin-related
proteins may be likely candidates for targeting mSWI/
SNF or BAF complexes to selective chromatin domains
(Zhao et al., 1998). CRP-interacting proteins, such as
zyxin and actin itself, have been found to contain an
NES (nuclear export sequence) and to shuttle between
the cytoplasm and nucleus (Nix and Beckerle, 1997;
Wada et al., 1998). Hypothetically, CRPs may be in-
Figure 6. A Dominant-Negative CRP2 Mutant Blocks Vascular
volved in chromatin remodeling by being physically as-Smooth Muscle Differentiation of Proepicardial Organ (PEO) Cells
sociated to an actin-based nuclear matrix that shuttles
(A) Luciferase reporter assay was performed to measure the tran-
from the cytoskeleton to the nucleus (Figure 7). Nuclearscriptional activity of SMA in CV1 cells, with the indicated combina-
nonmuscle actinins and/or zyxin isoforms might servetion of expression plasmids. Mutant CRP2 plasmids, CRP2N or
as molecular tethers that recruit LIM-associated tran-CRP2C, were cotransfected with wild-type CRP2 in a 1:1 (lanes 5
and 8), 1:2 (lanes 6 and 9), or 1:5 ratio (lanes 7 and 10). scriptosomes to the actin matrix, thus increasing the
(B) Freshly isolated PEO explants were transfected with CRP2N local concentration of transcription factors. Short oligo-
mutant or wild-type CRP2 plasmids. Double-immunofluorescent mers of actin may lead to the placement of transcripto-
staining of V5-tagged CRP2N or CRP2 (green) was implemented some complexes periodically along a short actin fila-
2 to 3 days later to evaluate the effect on SMC marker protein
ment (Figure 7). These actin-based nuclear complexes,expression (red). Indirect immunofluorescence analysis shows that
in essence, might form a semi-rigid platform that couldPEO cells that expressed the dominant-negative mutant did not
help bend or twist chromatin to optimize transcriptionalcoexpress SMA, calponin, or SMA (white arrows). In contrast, wild-
type CRP2 expression did not interfere with SMC marker protein activity. An actin-based nuclear matrix with associated
SMA expression (yellow arrows). nuclear myosins (Nowak et al., 1997) may even provide
motor activity that twists chromatin. The ability of SRF,
GATA6, and CRP2, in combination, but not individually,
which have been shown to assemble transcription factor to activate SMC-restricted marker genes, such as SMA,
complexes involved in myogenic, erythrogenic, and neu- SM22, calponin, caldesmon, and SM-MHC (Figure 5B),
rogenic gene regulation, respectively (Kong et al., 1997; may be due to the ability of LIM factors to assemble
Mead, et al. 2001; Bao et al., 2000). The three-dimen- transcriptosome complexes and facilitate chromatin re-
sional structure of CRP2 revealed individual LIM do- modeling. Future studies will test this possibility and
examine the roles of other LIM domain-containing genemains as independent structural modules separated by
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Figure 7. A Model for CRP2’s Dual Roles: A
LIM-Only Shuttling Protein that Functions
Both as a Cytoplasmic Scaffold Protein and
as a Nuclear Transcription Cofactor
In early progenitor cells, CRP2’s nuclear lo-
calization allows for formation of transcrip-
tion complexes that might associate with an
actin-based nuclear matrix to activate tran-
scription of an SRF-dependent target gene.
Strong activation may partly be due to the
effect of CRP2, which greatly increased
SRF’s DNA binding affinity to target promot-
ers containing multiple SREs. CRP2 may work
as a molecular adaptor to assemble a tran-
scriptosome consisting of SRF, GATA6, and
other essential factors on SMC-restricted
promoters. Hypothetically, CRPs might also
augment transcriptional activity via chroma-
tin remodeling by being physically associated
to an actin-based nuclear matrix linked with
nonmuscle actinins and/or zyxin that shuttle
from the cytoskeleton to the nucleus. Nuclear
nonmuscle actinins and/or zyxin isoforms as
molecular tethers or linkers that might recruit
LIM-associated transcriptosomes to the ac-
tin matrix. These nuclear short actin fibrils
might allow associated CRP transcripto-
somes to bind multiple DNA gene targets. The
cytoplasmic colocalization of CRP2 with ma-
ture muscle filaments may be related to the
strong binding of the N-terminal LIM domain
to the cytoskeleton-associated proteins,
such as -actinin and zyxin.
(SMA, 1A4), h-caldesmon (hHCD), calponin (hCP), SM-MHCfamilies in specification of different cardiovascular lin-
(HSM-V), sarcomeric -actin (5C5), and avian calponin (CP-93) wereeages by recruitment and assembly of multiprotein com-
from Sigma; smooth muscle -actin (SMGA, B4) was from ICN;plexes that confer lineage-specific gene transcription.
epitope tags V5, Myc (Invitrogen), HA-probe (Santa Cruz), and FLAG
(M2, Sigma) were purchased commercially. Monoclonal anti-SM22
Experimental Procedures
(1A8) was a generous gift from Dr. Saverio Sartore (Padua, Italy).
Expression Vectors and Reporter Genes
Whole-Mount In Situ Hybridization of CRP1Luciferase reporter plasmids Gal4-Luc, SMA-Luc, SM22-Luc, and
and CRP2 in Early Chick Embryosc-fosSRE1-Luc and expression vectors pCGN-SRF, pCGN-SRFC,
For the examination of the expression patterns of CRP1 and CRP2,pCGN-GATA2, pcDNA-GATA6, Gal-DB, Gal-MADS, and MBP-
antisense probes were synthesized from the chick partial cDNAsGATA4 were described previously (Sepulveda et al., 1998; Belaguli
covering nucleotides 49–941 (CRP1) and 4–806 (CRP2). Whole-et al., 2000). V5-tagged full-length CRP2 (aa 1–193) and deletion
mount in situ hybridization of chick embryos was carried out asmutants CRP2N (aa 1–112), CRP2ZF1 (aa 35–193), CRP2C (aa
described (Yamada et al., 1999).113–193), CRP2ZF2ZF3 (aa 35–145), and CRP2ZF4 (aa 1–145)
were constructed by ligation of PCR-amplified fragments from rat
Transfection Assays to Assess SMC Target Gene PromoterspBSSK-CRP2 into eukaryotic expression vectors pCDNA3.1D/V5
CV1 cells were grown and maintained at subconfluence (70%)(Invitrogen). HA-tagged full-length rat CRP2 was generated by sub-
level in Dulbecco’s modified Eagle’s medium (DMEM) containingcloning CRP2 fragment from pBSSK-CRP2 into CMV-driven expres-
10% fetal bovine serum. Transient transfections were performedsion vector pCGN. Myc-tagged full-length mouse GATA4 (1–440)
with Fugene 6 (Roche) according to the manufacturer’s recommen-and deletion mutants G4N (188–440), G4NZF1 (248–440),
dation. A series of luciferase assays was performed by transientG4ZF1ZF2 (188–335), G4C (1–304), and G4ZF2C (1–249)
transfection in a combination of CMV-driven expression vectors,were constructed by ligation of RT-PCR-amplified fragments into
pCGN-SRF (200 ng), pcDNA-myc-GATA6 (400 ng), pcDNA-V5-CRP2eukaryotic expression vectors pCDNA3.1-myc-His (Invitrogen), gen-
(500 ng), and pCGN-SRFC, luciferase reporters (200 ng), and emptyerous gifts from Carl Brown (Houston, TX). Myc-tagged full-length
expression vectors, pCGN, to a balanced total of 1.3 	g of plasmidschicken GATA6 (1–443) was constructed by ligating PCR-amplified
per 2 cm-diameter well of a 12-well plate. For one-hybrid analysisfragments from pCDNA-GATA6 into eukaryotic expression vectors
of recruitment of CRP2 by a Gal-MADS fusion, luciferase reporterpCDNA3.1-myc-His (Invitrogen). Full-length human SRF or rat CRP2
Gal-Luc (200 ng), Gal-DB (200 ng), or Gal-MADS (200 ng) and CRP2cDNA were cloned into pGEX-2T (Stratagene) to construct bacterial
(500 ng) or CRP2-VP16 (500 ng) were used. Cotransfection experi-expressed GST-SRF and GST-CRP2 vectors. Luciferase reporters,
ments were performed in duplicate and repeated at least three times.cloned in pGL2 (Promega), SMGA5-Luc (from Dr. Warren Zimmer,
Luciferase activity was normalized to baseline reporter gene activityMobile, Alabama) and 549Calp-LucI (from Dr. Joseph Miano, Mil-
as fold activation, with error bars representing SEM.waukee, Wisconsin), were generous gifts. Expression vector
pcDNA-FLAG-E12 was a generous gift from Dr. Eric Olson (Dallas,
Texas). Coimmunoprecipitation of CRP2, SRF, and GATA4
CV1 fibroblasts were cotransfected with epitope-tagged expression
vectors pcDNA-V5-CRP2, pCGN-SRF (HA), pcDNA-myc-GATA6,Antibodies
Polyclonal rabbit anti-chicken CRP2 antibodies were generated by and pcDNA-FLAG-E12. Approximately 100 	g of total protein were
incubated with different primary antibodies against specific epitopesLouis et al. (1997). Monoclonal antibodies for smooth muscle -actin
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(anti-V5, 2 	l/ml; anti-HA, 10 	l/ml; anti-Myc, 2	l/ml; anti-FLAG, of neurogenesis by interactions between HEN1 and neuronal LMO
proteins. Development 127, 425–435.2	l/ml) and retrieved with protein G Sepharose resin. Coimmuno-
precipitated proteins were resolved on 4%–20% SDS-polyacryl- Belaguli, N.S., Zhou, W., Trinh, T., Majesky, M.W., and Schwartz, R.J.
amide gel and then subjected to Coomassie staining (data not (1999). Dominant negative murine serum response factor: alternative
shown) or Western immunoblot analysis (anti-V5, 1:5000; anti-HA, splicing within the activation domain inhibits transactivation of se-
1:1000; anti-Myc, 1:5000; anti-FLAG, 1:5000). rum response factor binding sites. Mol. Cell. Biol. 19, 4582–4591.
Belaguli, N.S., Sepulveda, J.L., Nigam, V., Charron, F., Nemer, M.,
Electrophoretic Mobility Assays of SRF and Cofactors
and Schwartz, R.J. (2000). Cardiac tissue enriched factors serum
PCR-amplified double-stranded oligonucleotides (141 to1) from
response factor and GATA-4 are mutual coregulators. Mol. Cell.
the 5
 flanking sequence of murine smooth muscle -actin (M57409)
Biol. 20, 7550–7558.
containing SRE1 and SRE2 were used for electrophoretic mobility
Colas, J.F., Lawson, A., and Schoenwolf, G. (2000). Evidence thatshift assays, as previously described (Sepulveda et al., 1998).
translation of smooth muscle alpha actin mRNA is delayed in the
chick promyocardium until fusion of the bilateral heart forming re-In Vitro Pull-Down Assays
gions. Dev. Dyn. 218, 316–330.Recombinant fusion proteins GST-CRP2, GST-SRF, and MBP-
GATA4 and control GST and MBP were expressed in bacteria (Sep- Chang, K.S., Zimmer, W.E., Jr., Bergsma, D.J., Dodgson, J.B., and
ulveda et al., 1998) and affinity purified. In vitro translation of various Schwartz, R.J. (1984). Isolation and characterization of six different
[35S] methionine-labeled protein products were performed with rab- chicken actin genes. Mol. Cell. Biol. 4, 2498–2508.
bit reticulocyte lysates from TnT In Vitro Translation kit (Promega). Dawid, I.B., Toyama, R., and Taira, M. (1995). LIM domain proteins.
Pull-down assay was performed as previously described (Sepulveda C. R. Acad. Sci. III 318, 295–306.
et al., 1998).
Dugaiczyk, A., Haron, J.A., Dennison, O., Stone, E.M., Rothblum,
K.N., and Schwartz, R.J. (1983). Cloning of a DNA copy of glyceralde-Transdifferentiation Assays in Pluripotent 10T1/2 Cells
hyde-3-phosphate dehydrogenase messenger RNA isolated fromMurine pluripotent 10T1/2 fibroblasts (ATCC) between passages 5
chicken muscle: complete nucleic acid sequence of coding region.and 12 were maintained at low confluence (25%) in DMEM con-
Biochemistry 22, 1605–1613.taining 2% horse serum. Transfection in combination of different
Flick, M.J., and Konieczny, S.F. (2000). The muscle regulatory andexpression plasmids (3 	g each) was performed with Fugene 6. Two
structural protein MLP is a cytoskeletal binding partner of betaI-days after transfection, half of the cells per plate were extracted for
spectrin. J. Cell Sci. 113, 1553–1564.RNA with an RNeasy Kit (Qiagen) and treated with RNase-free DNase
I. RT-PCR assays were carried out on the extracted RNA with spe- Gineitis, D., and Treisman, R. (2001). Differential usage of signal
cific primers for SMA, SM22, calponin, SM-MHC (Yamashita et transduction pathways defines two types of serum response factor
al., 2000), cardiac -actin, SMGA (Chang et al., 1984), and GAPDH target gene. J. Biol. Chem. 276, 24531–24539.
(Dugaiczyk et al., 1983). Approximately 2 weeks after transfection,
Henderson, J.R., Macalma, T., Brown, D., Richardson, J.A., Olson,95% of cells were harvested for Western immunoblot analysis, while
E.N., and Beckerle, M.C. (1999). The LIM protein, CRP1, is a smooththe remaining 5% of cells were plated on glass slides for indirect
muscle marker. Dev. Dyn. 214, 229–238.immunofluorescence analysis.
Jain, M.K., Fujita, K.P., Hsieh, C.M., Endege, W.O., Sibinga, N.E.,
Yet, S.F., Kashiki, S., Lee, W.S., Perrella, M.A., Haber, E., and Lee,Isolation of Proepicardial Organ (PEO) Cells
M.E. (1996). Molecular cloning and characterization of SmLIM, aQuail stage HH17 PEOs were dissected and cultured as described
developmentally regulated LIM protein preferentially expressed in(Landerholm et al., 1999). For localization of endogenous CRP2
aortic smooth muscle cells. J. Biol. Chem. 271, 10194–10199.protein, explanted PEOs were cultured in glass chamber slides for
3 to 5 days and then characterized by immunofluorescence assays, Kim, S., Ip, H., Lu, M., Clendenin, C., and Parmacek, M.S. (1997). A
as described (Lu et al., 2001), with primary antibodies (CRP2, 1:200; serum response factor-dependent transcriptional regulatory pro-
Probes). gram identifies distinct smooth muscle cell sublineages. Mol. Cell.
Biol. 17, 2266–2278.
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